A group of more than 650 nephrologists have joined with Fresenius Medical Care North America (FMCNA), the nation’s leading provider of kidney care products and services, to raise $20 million in initial funding and announce the formation of InterWell Health, a population health management company focused on supporting the renal patient population across the full continuum of care.
| WALTHAM, Mass., Dec. 18, 2019 /PRNewswire/ -- A group of more than 650 nephrologists have joined with Fresenius Medical Care North America (FMCNA), the nation’s leading provider of kidney care products and services, to raise $20 million in initial funding and announce the formation of InterWell Health, a population health management company focused on supporting the renal patient population across the full continuum of care.
Over the past several years, InterWell Health investors have participated in various value based arrangements, including the End Stage Renal Disease Seamless Care Organization (ESCO) program. With this experience and expertise as the newly-formed entity’s foundation, InterWell Health will facilitate and support renal providers across the country to create value in managing the chronic kidney disease and end stage renal disease patient population by improving patient outcomes and lowering overall costs to the system. “We are now well-positioned to accelerate the transition from volume to value under clinical care models and resources developed under a physician-driven governance model,” said Dylan Steer, MD, President of Balboa Nephrology in San Diego, California. “We are proud to be part of this innovative, patient-focused organization.” InterWell Health will foster collaboration among clinicians across the country to support their value based operations. The combined clinical and analytical expertise of the nephrology practices and FMCNA will be leveraged to provide shared know-how, state-of-the-art models of care, and other resources for value based arrangements in local and national markets. “InterWell Health is uniquely positioned to expand its high-performing network of renal providers to collaborate with both public and private payors under value based arrangements,” said Bill Valle, InterWell Health Board Member and Chief Executive Officer for FMCNA. “It combines the expertise of a diverse and preeminent group of nephrology practices with the experience of FMCNA and aims to advance value based contracting models that are attractive to payors and patients by driving better clinical outcomes at lower costs.” “This is the next step in value based care and will provide the blueprint for all renal providers to engage in these types of arrangements,” said Ravindra Bollu, MD, Managing Partner of Kidney Care Specialists LLC in Bethlehem, Pennsylvania. “We believe with strong physician leadership, InterWell Health is well positioned to advance a rapid transformation of renal care models.” About InterWell Health About Fresenius Medical Care North America Media Contact:
SOURCE Fresenius Medical Care Holdings, Inc. |
View original content to download multimedia:
